Business, energy, technology, markets and global industry news from Business News Today

Medical Devices & Diagnostics

PharmaDeviceNews Medical Devices & Diagnostics
Representative image: A clinician uses an energy-based laser device in a modern dermatology clinic, reflecting how Lumenis’ ASLMS clinical data could strengthen evidence-led treatment pathways for hair loss, rhinophyma and skin rejuvenation in medical aesthetics.
Medical Devices & Diagnostics

Lumenis strengthens FoLix, ULTRApulse Alpha and Stellar M22 case with ASLMS data

Aesthetics needs stronger evidence. Lumenis is using ASLMS data to push lasers deeper into hair loss, skin and rhinophyma care.

Read More
KUBTEC Scientific’s XCELL TomoRad targets a major bottleneck in preclinical radiotherapy studies
Medical Devices & Diagnostics

Can KUBTEC Scientific lower the barrier to image-guided radiotherapy in cancer research?

Preclinical IGRT is powerful but costly. KUBTEC Scientific’s XCELL TomoRad tests whether access, speed, and targeting can finally align.

Read More
Representative image: Co-Diagnostics’ CoMira Diagnostics lease in Saudi Arabia highlights the growing push for localized molecular diagnostics manufacturing, PCR platform readiness, and healthcare supply-chain resilience under Vision 2030.
Medical Devices & Diagnostics

Could Co-Diagnostics’ Saudi manufacturing move strengthen its molecular diagnostics strategy?

Saudi localization gives Co-Diagnostics a new opening. The test is whether CoMira can turn a factory lease into diagnostics traction.

Read More
Representative image of a cardiovascular specialist reviewing advanced aortic imaging, reflecting Artivion’s Endospan acquisition strategy and the NEXUS Aortic Arch System opportunity as the company expands its aortic disease portfolio despite a lowered 2026 outlook.
Medical Devices & Diagnostics

Artivion just bought a bigger aortic future, but investors may not love the waiting game

Artivion’s aortic portfolio is getting stronger, but its 2026 outlook is getting weaker. Can Endospan turn strategy into growth?

Read More
Representative image of shaped allograft implants prepared in a sterile surgical setting, reflecting Xtant Medical’s Trivium Shaped launch and the growing focus on workflow efficiency in spine and orthopedic procedures.
Medical Devices & Diagnostics

Can Trivium Shaped help Xtant Medical sharpen its orthobiologics growth story?

Bone graft convenience is becoming a medtech battleground. Xtant Medical’s Trivium Shaped launch tests whether workflow gains can drive adoption.

Read More
Representative image: AI-powered digital pathology analysis could help reshape breast cancer risk stratification after ArteraAI Breast became the first FDA-cleared pathology-based breast cancer risk tool in the United States.
Medical Devices & Diagnostics

Can ArteraAI Breast turn routine pathology slides into breast cancer risk intelligence?

AI can read pathology slides, but can it change breast cancer treatment decisions? ArteraAI Breast puts that question before clinicians and payers.

Read More
Representative image: A modern hospital medication management setup showing automated dispensing, infusion technology and clinical workflow integration, reflecting BD and Wellstar Health System’s push to improve medication delivery, pharmacy visibility and patient safety through connected hospital systems.
Medical Devices & Diagnostics

Why BD’s Wellstar partnership could reshape medication delivery inside hospitals

Hospitals need safer medication delivery, not more disconnected tech. BD and Wellstar are testing whether AI can close that workflow gap.

Read More
Representative image of a transport-ready ECMO system in a critical care transfer setting, reflecting Medtronic plc’s CE mark approval for the VitalFlow Transport Frame Air and Ground in Europe.
Medical Devices & Diagnostics

Medtronic just cleared a key ECMO transport hurdle, but hospitals still face the harder test

ECMO transport is a clinical weak point. Medtronic’s VitalFlow CE mark tests whether device mobility can strengthen critical care networks.

Read More
Representative image of a robotic-assisted soft tissue surgery setting, highlighting how Johnson & Johnson’s OTTAVA pivotal gastric bypass study could intensify competition in advanced surgical robotics.
Medical Devices & Diagnostics

Johnson & Johnson clears a key OTTAVA hurdle, but the harder robotics test comes next

Robotic surgery is opening up. Johnson & Johnson’s OTTAVA data may test whether hospitals want a new soft tissue platform.

Read More
Representative image: A modern radioligand therapy manufacturing centre under construction in Texas, highlighting Novartis AG’s investment in U.S. oncology infrastructure and the growing race to scale precision cancer treatment supply chains.
Medical Devices & Diagnostics

Novartis bets on Texas as radioligand therapy moves closer to mainstream oncology

RLT demand is rising faster than supply chains can stretch. Novartis’ Texas buildout tests whether precision oncology can scale.

Read More